Indications and uses
for the temporary relief of symptoms commonly associated with allergies, such as: • watery eyes • coughing • sneezing • congestion Indications based on Homeopathic Materia Medic for self-limiting conditions.
for the temporary relief of symptoms commonly associated with allergies, such as: • watery eyes • coughing • sneezing • congestion Indications based on Homeopathic Materia Medic for self-limiting conditions.
Dispense Claritose directly into mouth, or add recommended dosage into 8-12 oz. of purified (non-chlorinated) water and drink. Safe for ages 2 and up.
• do not use if tamper seal is broken • store in a cool, dry place • product must not come in contact with metal • do not store next to electrical devices or appliances
Allium cepa HPUS
Ambrosia artemisiaefolia HPUS
Arsenicum album HPUS
Arundo mauritanica HPUS
Arum triphyllum HPUS
Euphrasia officinalis HPUS
Naphthalinum HPUS
Natrum muriaticum HPUS
Sabadilla HPUS
Wyethia helenioides HPUS
Each active ingredient contains equal volumes of 10X, 30X, and LM1 potencies. The letters “HPUS” indicate that the components in this product are officially monographed in the Homeopathic Pharmacopoeia of the United States. Product indications are based on Homeopathic Materia Medica.
Allium cepa HPUS……………………………………………….Watery eyes
Ambrosia artemisiaefolia HPUS……………………………… Sneezing
Arsenicum album HPUS……………………………………….Wheezing
Arundo mauritanica HPUS……………………………………Cough
Arum triphyllum HPUS………………………………………...Hoarseness
Euphrasia officinalis HPUS..…………………………………Eye pressure
Naphthalinum HPUS…………………………………………..Hay Fever
Natrum muriaticum HPUS…………………………………….Difficult breathing
Sabadilla HPUS…………………………………………………Nasal discharge
Wyethia helenioides HPUS……………………………………Headache
for the temporary relief of symptoms commonly associated with allergies, such as:
• watery eyes
• coughing
• sneezing
• congestion
Indications based on Homeopathic Materia Medic for self-limiting conditions.
Ask a doctor before use if
When using this product, use only as directed.
Stop use and ask a doctor if symptoms persist or worsen.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of the reach of children.
Dispense Claritose directly into mouth, or add recommended dosage into 8-12 oz. of purified (non-chlorinated) water and drink. Safe for ages 2 and up.
30-50 lbs 1/2 mL
(13.6-22.6 kg) twice per day
50+ lbs 1 mL
(22.6+ kg) twice per day
• do not use if tamper seal is broken
• store in a cool, dry place
• product must not come in contact with metal
• do not store next to electrical devices or appliances
citric acid, potassium sorbate, purified ionized mineral water.
You can email us at
info@hellolife.net or call us toll-free at
1.800.875.0850. Monday through Friday, 9am-5pm ET
Mftd for: HelloLife, Inc. 4460 44th St. SE, Ste. C-600 Grand Rapids, MI 49512 FDA Pharmaceutical Establishment #1053442, #3009727070 |
NDC 49726-006-02
CLARITOSE®
Allergy Symptom Relief
For the temporary relief of symptoms commonly associated with allergies, such as:
2 fl oz (59 mL)
Homeopathic (OTC) Medicine
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 49726-006-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-f949-f424-e053-dadaa90a57ce | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49726-006-02 | Claritose | 1 in 1 CARTON | LIQUID | 1 | 11 | |
| 49726-006-02 | Claritose | 59 mL in 1 BOTTLE, DROPPER | LIQUID | 59 | 11 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 49726-006 | CLARITOSE (ALLIUM CEPA, AMBROSIA ARTEMISIAEFOLIA, ARSENICUM ALBUM, ARUNDO MURITANICA, ARUM TRIPHYLIUM, EUPHRASIA OFFICINALIS, NAPHTHALINUM, NATRUM MURIATICUM, SABADILLA, WYETHIA HELENIODES) LIQUID [HELLO LIFE, INC.] | 11 | Legacy NDC, 2 package rows | 20181227_5f2b191e-04a4-4c5a-940e-757cb544c189.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| AMBROSIA ARTEMISIIFOLIA | ACTIVE INGREDIENT | 9W34L2CQ9A | 10 | |
| ARISAEMA TRIPHYLLUM ROOT | ACTIVE INGREDIENT | DM64K844DM | 10 | |
| ARSENIC TRIOXIDE | ACTIVE INGREDIENT | S7V92P67HO | 10 | |
| ARUNDO PLINIANA ROOT | ACTIVE INGREDIENT | ZXE7LB03WC | 10 | |
| EUPHRASIA STRICTA | ACTIVE INGREDIENT | C9642I91WL | 10 | |
| NAPHTHALENE | ACTIVE INGREDIENT | 2166IN72UN | 10 | |
| ONION | ACTIVE INGREDIENT | 492225Q21H | 10 | |
| SCHOENOCAULON OFFICINALE SEED | ACTIVE INGREDIENT | 6NAF1689IO | 10 | |
| SODIUM CHLORIDE | ACTIVE INGREDIENT | 451W47IQ8X | 10 | |
| WYETHIA HELENIOIDES ROOT | ACTIVE INGREDIENT | J10PD1AQ0N | 10 | |
| AMBROSIA ARTEMISIIFOLIA | ACTIVE MOIETY | 9W34L2CQ9A | 10 | |
| ARISAEMA TRIPHYLLUM ROOT | ACTIVE MOIETY | DM64K844DM | 10 | |
| ARSENIC CATION (3+) | ACTIVE MOIETY | C96613F5AV | 10 | |
| ARUNDO PLINIANA ROOT | ACTIVE MOIETY | ZXE7LB03WC | 10 | |
| CHLORIDE ION | ACTIVE MOIETY | Q32ZN48698 | 10 | |
| EUPHRASIA STRICTA | ACTIVE MOIETY | C9642I91WL | 10 | |
| NAPHTHALENE | ACTIVE MOIETY | 2166IN72UN | 10 | |
| ONION | ACTIVE MOIETY | 492225Q21H | 10 | |
| SCHOENOCAULON OFFICINALE SEED | ACTIVE MOIETY | 6NAF1689IO | 10 | |
| WYETHIA HELENIOIDES ROOT | ACTIVE MOIETY | J10PD1AQ0N | 10 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | 10 | |
| POTASSIUM SORBATE | INACTIVE INGREDIENT | 1VPU26JZZ4 | 10 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 10 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 49726-006 | 49726-006-02 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| POTASSIUM SORBATE | 1VPU26JZZ4 | IACT |
| WATER | 059QF0KO0R | IACT |
| CITRIC ACID MONOHYDRATE | 2968PHW8QP | IACT |
| ONION | 492225Q21H | ACTIB |
| AMBROSIA ARTEMISIIFOLIA | 9W34L2CQ9A | ACTIB |
| ARSENIC TRIOXIDE | S7V92P67HO | ACTIB |
| ARUNDO PLINIANA ROOT | ZXE7LB03WC | ACTIB |
| ARISAEMA TRIPHYLLUM ROOT | DM64K844DM | ACTIB |
| EUPHRASIA STRICTA | C9642I91WL | ACTIB |
| NAPHTHALENE | 2166IN72UN | ACTIB |
| SODIUM CHLORIDE | 451W47IQ8X | ACTIB |
| SCHOENOCAULON OFFICINALE SEED | 6NAF1689IO | ACTIB |
| WYETHIA HELENIOIDES ROOT | J10PD1AQ0N | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAOCULAR | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRALESIONAL | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 385 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET / ORAL | 914 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | FILM, EXTENDED RELEASE / TRANSDERMAL | 1.38 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LOTION / TOPICAL | 0.85 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INFILTRATION | 0.02 %w/v | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | POWDER, FOR SUSPENSION / ORAL | 19 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | DROPS / ORAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, CHEWABLE / ORAL | 7 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CREAM / VAGINAL | 0.49 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION / ORAL | 269 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SHAMPOO / TOPICAL | 17 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 38 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SYRUP / ORAL | 2 mg/1ml | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | CAPSULE / ORAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / TOPICAL | 17 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / IONTOPHORESIS | 0.02 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / SUBCUTANEOUS | 28 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRAVENOUS | 396 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SOLUTION / ORAL | 315 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 0.2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAVENOUS | 10 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / BUCCAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SHAMPOO, SUSPENSION / TOPICAL | 0.25 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, ORALLY DISINTEGRATING / ORAL | 83 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / AURICULAR (OTIC) | 0.2 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION, EXTENDED RELEASE / ORAL | 140.8 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, COATED / ORAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, EXTENDED RELEASE / ORAL | 45 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRA-ARTICULAR | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION, CONCENTRATE / INTRAOCULAR | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / RESPIRATORY (INHALATION) | 8 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / EPIDURAL | 0.02 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | EMULSION / TOPICAL | 0.11 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | ELIXIR / ORAL | 100 mg/5ml | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | LOTION / TOPICAL | 0.2 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CONCENTRATE / ORAL | 5.3 mg/1ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION/ DROPS / AURICULAR (OTIC) | 0.04 %w/w | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | PASTE / ORAL | 48 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | AEROSOL, FOAM / TOPICAL | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / SOFT TISSUE | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CREAM / TOPICAL | 4 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | GRANULE, FOR SUSPENSION / ORAL | 80 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION / RESPIRATORY (INHALATION) | 0.03 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAMUSCULAR | 0.05 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SWAB / TOPICAL | 0.05 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | AEROSOL, FOAM / RECTAL | 7 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SPRAY / NASAL | 9 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION / RECTAL | 6.67 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION/ DROPS / ORAL | 19 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRAMUSCULAR | 26 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TROCHE / ORAL | 12 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | GEL / TOPICAL | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / INTRAVENOUS | 0.2 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SUSPENSION / ORAL | 840 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / RESPIRATORY (INHALATION) | 0.13 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYRUP / ORAL | 722 mg/5ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | NA |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 7df0b4ca-2f36-e8e5-e053-2991aa0af9ee | 5f2b191e-04a4-4c5a-940e-757cb544c189 | 2018-12-26 | Warnings | 7df0b4ca-2f36-e8e5-e053-2991aa0af9ee 5f2b191e-04a4-4c5a-940e-757cb544c189 |
Adverse event summaries are temporarily unavailable. Other product information remains available.